| GTO ID | GTC2423 |
| Trial ID | NCT04509726 |
| Disease | Nasopharyngeal Disease |
| Altered gene | EBV |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | EBV TCR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Single-Arm Trial of EBV Specific Cytokine Secreting TCR-T Cells in the Treatment of EBV-Positive Head and Neck Carcinoma Metastatic/Refractory Nasopharyngeal Carcinoma |
| Year | 2020 |
| Country | China |
| Company sponsor | Xinqiao Hospital of Chongqing |
| Other ID(s) | XQDC20200801 |
| Cohort 1 | |||||||||
|
|||||||||